Literature DB >> 8127055

Ineffectiveness of captopril in reducing cystine excretion in cystinuric children.

H Michelakakis1, D Delis, V Anastasiadou, C Bartsocas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8127055     DOI： 10.1007/bf00711523

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  4 in total

1.  Cystinuria: failure of captopril to reduce cystine excretion.

Authors:  P J Dahlberg; J D Jones
Journal:  Arch Intern Med       Date:  1989-03

2.  Captopril reduces urinary cystine excretion in cystinuria.

Authors:  J A Sloand; J L Izzo
Journal:  Arch Intern Med       Date:  1987-08

3.  In vitro biotransformations of [14C]captopril in the blood of rats, dogs and humans.

Authors:  K K Wong; S Lan; B H Migdalof
Journal:  Biochem Pharmacol       Date:  1981-10-01       Impact factor: 5.858

4.  Effect of captopril on urinary cystine excretion in homozygous cystinuria.

Authors:  S B Streem; P Hall
Journal:  J Urol       Date:  1989-12       Impact factor: 7.450
  4 in total
  3 in total

Review 1.  Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up.

Authors:  Thomas Knoll; Antonia Zöllner; Gunnar Wendt-Nordahl; Maurice Stephan Michel; Peter Alken
Journal:  Pediatr Nephrol       Date:  2004-11-25       Impact factor: 3.714

Review 2.  How should patients with cystine stone disease be evaluated and treated in the twenty-first century?

Authors:  Kim Hovgaard Andreassen; Katja Venborg Pedersen; Susanne Sloth Osther; Helene Ulrik Jung; Søren Kissow Lildal; Palle Joern Sloth Osther
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

3.  Cystine crystal volume determination: a useful tool in the management of cystinuric patients.

Authors:  Michel Daudon; Fabrice Cohen-Solal; Frédéric Barbey; Marie-France Gagnadoux; Bertrand Knebelmann; Paul Jungers
Journal:  Urol Res       Date:  2003-05-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.